Ma Yuanyuan, Zhou Zhiyuan, Yang Guo-Yuan, Ding Jing, Wang Xin
Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai, China.
Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Front Pharmacol. 2022 Feb 17;13:743926. doi: 10.3389/fphar.2022.743926. eCollection 2022.
Numerous studies explored the therapeutic effects of erythropoietin (EPO) on neurodegenerative diseases. Few studies provided comprehensive and latest knowledge of EPO treatment for ischemic stroke. In the present review, we introduced the structure, expression, function of EPO, and its receptors in the central nervous system. Furthermore, we comprehensively discussed EPO treatment in pre-clinical studies, clinical trials, and its therapeutic mechanisms including suppressing inflammation. Finally, advanced studies of the therapy of EPO derivatives in ischemic stroke were also discussed. We wish to provide valuable information on EPO and EPO derivatives' treatment for ischemic stroke for basic researchers and clinicians to accelerate the process of their clinical applications.
众多研究探讨了促红细胞生成素(EPO)对神经退行性疾病的治疗作用。很少有研究提供关于EPO治疗缺血性中风的全面且最新的知识。在本综述中,我们介绍了EPO的结构、表达、功能及其在中枢神经系统中的受体。此外,我们全面讨论了EPO在临床前研究、临床试验中的治疗情况及其治疗机制,包括抑制炎症。最后,还讨论了EPO衍生物治疗缺血性中风的前沿研究。我们希望为基础研究人员和临床医生提供有关EPO和EPO衍生物治疗缺血性中风的有价值信息,以加速其临床应用进程。